• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Friday, November 20, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Biology

Breast Development Workshop Highlights Cellular Potency, Microenvironments, and Natural Rhythms

by
November 20, 2026
in Biology
Reading Time: 6 mins read
0
Breast Development Workshop Highlights Cellular Potency, Microenvironments, and Natural Rhythms

Breast Development Workshop Highlights Cellular Potency, Microenvironments, and Natural Rhythms

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

The European Network for Breast Development and Cancer convened its fifteenth annual workshop on Methods in Mammary Gland Biology and Breast Cancer in Weggis, Switzerland, bringing together fifty-two principal investigators, postdoctoral fellows, and doctoral candidates from Europe, the United States, and Hong Kong. Hosted between May 2nd and May 4th, 2024, the meeting centered on methodological innovations and cross-disciplinary analyses of normal mammary development, malignant transformation, metastatic dissemination, and the epigenetic and metabolic regulation of breast cancer. Because the scientific and poster sessions focused primarily on unpublished experimental data, presentations highlighted technical bottlenecks, emerging model systems, and mechanistic discoveries that are actively shaping preclinical oncology and developmental biology.

Preceding the main symposium, the second annual Early Career Researcher workshop was organized by Maria Rafaeva of University Hospital Basel, Jaime Redondo-Pedraza of the Spanish National Cancer Research Centre, and Beata Kaczyńska of the University of Helsinki. Attended by fourteen junior scientists, the introductory program opened with presentations focused on bioengineered models of the human mammary gland. Anthony Wilby from the University of Manchester presented an intact human breast explant model designed to overcome the rapid loss of hormone responsiveness, cellular proliferation, and immune residency common to conventional organotypic cultures. Wilby demonstrated that this explant system successfully preserves breast epithelial proliferation, hormone receptor expression, and resident populations of macrophages and T-cells, providing a preclinical platform to evaluate risk factors such as tissue density and to test preventative agents aimed at reducing breast cancer incidence.

Methodological advances in spatial tissue engineering continued with Leena Koskinen from the University of Turku, who established an extrusion three-dimensional bioprinting protocol to reconstruct the branched morphology of the mammary ductal tree in hydrogel matrices. Koskinen patterned normal and malignant mammary epithelial cells into defined Y-shaped geometries, observing that cell proliferation rates peaked at the outermost branch tips furthest from the bifurcation point. Furthermore, bioprinted cancer cells acquired an invasive phenotype that was mitigated through the pharmacological inhibition of transforming growth factor-beta. In parallel, Kamyab Saberiseyedabad of VIB-KU Leuven presented dynamic spatial mapping of healthy human breast tissues, utilizing serial haematoxylin and eosin reconstructions alongside multiplex imaging to assemble a three-dimensional breast atlas across diverse developmental stages. Complementing these tissue reconstructions with hormone and growth-factor organoid screens, Saberiseyedabad identified correlations between the presence of hormone-sensing luminal cells and the deprivation of specific factors such as epidermal growth factors and beta-oestradiol.

The second early-career session addressed cellular heterogeneity and clonal dynamics. Jiaoqi Cheng from the University of Southampton applied multiplex immunolabeling and deep learning-based whole-cell segmentation algorithms to human breast cancer specimens to investigate centrosome amplification, a structural aberration linked to tumor initiation and adverse clinical prognosis. Cheng examined how centrosome amplification interacts with annexin 1, a previously identified regulator of mitotic spindle orientation, to direct cell fate and tissue heterogeneity. Investigating clonal evolution in vivo, Candice Merle from the Institut Curie utilized an MMTV-PyMT luminal B mouse model engineered for barcode-based lineage tracing paired with single-cell RNA sequencing. This spontaneous barcoding platform tracked individual tumor clones and dynamic transcriptional programs across stages of primary tumor expansion and metastatic dissemination, seeking to identify the specific clonal subsets that drive aggressive disease.

Furthering dynamic in vitro modeling, Marika Caruso of VIB-KU Leuven detailed the generation of hormone-responsive organoids that recapitulate the distinct phases of postnatal mammary gland remodeling, including the estrous cycle, pregnancy, lactation, and involution. Caruso showed that exposure to tailored media stimulated the upregulation of progesterone receptor target genes during simulated estrus, the overexpression of milk-protein gene panels during lactation, and the formation of functional secretory alveoli that regressed into virgin-like ductal structures during involution. The early-career proceedings concluded with practical workshops: Johanna Englund of the University of Helsinki led a technical seminar on hypothesis formulation, experimental reproducibility, and research ethics, followed by a professional panel featuring Zoi Diamantopoulou, Daniel Lafkas, and Emily Marcinkevicius examining career pathways across academia, biotechnology, and scientific publishing.

The main workshop opened with a keynote address delivered by Jacco van Rheenen of the Netherlands Cancer Institute, who examined how mutant clones persist and expand within normal epithelial architecture despite carrying oncogenic driver mutations. Collaborating with Colinda Scheele and Ben Simons, van Rheenen tracked triple-negative breast cancer clones harboring Brca1 and p53 deletions in genetically engineered mice expressing the multicolor Confetti reporter. Intravital imaging revealed that basal and luminal clones possess an identical capacity to survive and establish persistent clonal fields. The researchers determined that clonal expansion across broad epithelial fields is fueled by the continuous loss and replacement of stem cells during estrous cycle-dependent turnover of ductal side branches. Notably, halting the hormonal cycle through surgical ovariectomy prevented mutant clones from spreading across tissues and completely blocked tumor formation.

Stromal contributions to mammary morphogenesis and early malignancy were highlighted in subsequent presentations. Jakub Sumbal from the Institut Curie and Masaryk University employed single-cell transcriptomics, spatial mapping, and lineage tracing to characterize peri-terminal end bud fibroblasts in the pubertal mammary gland. Sumbal demonstrated through organoid co-cultures that direct physical interaction with epithelial cells is required to induce this contractile fibroblast subtype and guide branching morphogenesis. Shifting to early neoplastic lesions, Emilia Peuhu from the University of Turku presented spatial transcriptomic and imaging mass cytometry analyses of ductal carcinoma in situ overexpressing HER2. Peuhu identified distinct stromal alterations surrounding areas of neoductgenesis, a process linked to elevated metastatic risk that currently lacks diagnostic biomarkers, and outlined a volumetric methodology to quantify human terminal ductal lobular units, from which the majority of breast malignancies arise.

Extracellular matrix signaling and lineage hierarchy in tumor initiation were detailed by Johanna Englund and Salah Elias. Englund reported that laminin alpha 5 is enriched in clinical luminal A and B breast cancer subtypes. In MMTV-PyMT mice, heterozygous deletion of the Lama5 gene reduced tumor incidence and proliferative indices, accompanied by sustained fibroblast growth factor receptor signaling that sensitized mutant organoids to chemical FGFR inhibition. Elias, from the University of Southampton, investigated how basal cells dictate lineage fate through oriented cell division in pregnant mouse models. Lineage tracing revealed that basal cells undergo a defined transition from symmetric to asymmetric division between pregnancy days 8.5 and 9.5, exhibiting bi-lineage potency capable of generating both luminal and basal progenitors when labeled between days 8.5 and 14.5 of gestation.

Cell identity perturbations and tumor-suppressive checkpoints were addressed in studies of pubertal signaling and integrin function. Jaime Redondo-Pedraza demonstrated that ectopic overexpression of the receptor activator of nuclear factor kappa-B in pubertal basal cells disrupts lineage fidelity, producing hybrid basal-luminal phenotypes, extensive hyperplasia, and spontaneous mammary tumorigenesis that accelerates upon progesterone administration. Complementing these findings, Marisa Martin Faraldo from the Institut Curie showed that integrin alpha-6 deficiency activates p16-dependent cell cycle arrest in pre-neoplastic tissues. This loss restricts the proliferation of luminal progenitor cells and suppresses the partial epithelial-to-mesenchymal transition typically induced by concurrent Brca1 and p53 loss, significantly delaying malignant transformation.

Presentations on metastatic progression elucidated both systemic and local regulatory mechanisms. Angela Nieto from the Instituto de Neurociencias described two distinct epithelial-to-mesenchymal transition trajectories in MMTV-PyMT tumors using single-cell transcriptomics: an embryonic-like invasive program localized at the tumor margin and an adult fibrosis-like inflammatory program confined to non-invasive central cells. Zoi Diamantopoulou from the CRUK Scotland Institute described how circadian rhythms govern hematogenous dissemination, demonstrating that circulating tumor cell clusters exhibit enhanced shedding and proliferation during rest and sleep phases. Examining metastatic organotropism, Joana Paredes from the University of Porto showed that secretomes from brain-tropic triple-negative breast cancer cell lines disrupt endothelial tight junctions, identifying the neuroendocrine peptide VGF and its cleaved fragment TLQP-21 as drivers of microglial activation and brain metastatic colonization in animal models.

Translational analyses of therapeutic resistance closed the scientific program. Alecia-Jane Twigger of the University of Cambridge outlined the Wellcome LEAP Delta Tissue Program, which integrates spatial transcriptomics and single-nuclei sequencing from the PARTNER trial into predictive computational models of neoadjuvant chemotherapy response. Sven Rottenberg of the University of Bern identified loss of the LRRC8A and LRRC8D volume-regulated anion channel subunits, regulated via NAA60-mediated N-terminal acetylation, as a cause of 50 percent reductions in platinum uptake and subsequent chemoresistance in Brca1- and p53-deficient tumors. In addition, Sara Sdelci from the Centre for Genomic Regulation presented evidence that nuclear lactate dehydrogenase B modulates therapy response via histone lactylation, while Elisabetta Marangoni from the Institut Curie demonstrated that inhibiting oxidative phosphorylation reverses palbociclib resistance in endocrine-resistant patient-derived xenografts.

The meeting concluded with the presentation of awards recognizing outstanding contributions from early-career investigators. Jakub Sumbal received the DeOme Award, Marika Caruso was awarded the Glukhova-Medina Poster Prize, Helga Bergholtz received the Hynes-Streuli Prize, Hugo Croizer earned the Watson-Rosen Prize, and Runyu Xia was presented with the Werb-Cardiff Prize. Organizers summarized the overarching themes of the 2024 symposium, emphasizing the direct influence of the estrous cycle and circadian rhythms on therapeutic response windows, the critical regulatory functions of stromal and matrix microenvironments, the conditional plasticity of stem cell potency during developmental transitions, and the convergence of metabolic pathways with epigenetic mechanisms of therapy resistance, looking ahead to the sixteenth meeting in April 2025.

Subject of Research: Mammary gland development, breast cancer biology, microenvironmental regulation, and therapeutic resistance

Article Title: 15th Annual ENBDC Meeting: How do Cellular Potency, Microenvironment and Natural Rhythms Influence Mammary Gland Biology and Breast Cancer?

Article References: Rafaeva, M., Kaczyńska, B., Redondo-Pedraza, J., Bentires-Alj, M., Khaled, W. T., & Fre, S. (2024). 15th Annual ENBDC Meeting: How do Cellular Potency, Microenvironment and Natural Rhythms Influence Mammary Gland Biology and Breast Cancer?. Journal of Mammary Gland Biology and Neoplasia, 29(1), Article 19. https://doi.org/10.1007/s10911-024-09572-2

Image Credits: AI Generated

DOI: 10.1007/s10911-024-09572-2

Keywords: mammary gland biology, breast cancer, circadian rhythms, estrous cycle, extracellular matrix, lineage tracing, triple-negative breast cancer, ductal carcinoma in situ, metastasis, circulating tumour cells, fibroblasts, 3D bioprinting, organoid models, therapy resistance, histone lactylation, oxidative phosphorylation

News Source: Nathaniel Bowman. (November 20, 2026). Breast Development Workshop Highlights Cellular Potency, Microenvironments, and Natural Rhythms. Scienmag.

Tags: 3D bioprintingBreast CancerCircadian Rhythmscirculating tumour cellsductal carcinoma in situestrous cycleextracellular matrixfibroblastsHistone lactylationlineage tracingmammary gland biologyMetastasisorganoid modelsoxidative phosphorylationtherapy resistancetriple-negative breast cancer
Share12Tweet7Share2ShareShareShare1

Related Posts

SARS-CoV-2 Beta Variant Drives Acute Lung Immune Activation in Wild-Type Mice

SARS-CoV-2 Beta Variant Drives Acute Lung Immune Activation in Wild-Type Mice

November 20, 2026
Survey Near Lal Suhanra National Park Identifies Thirty Traditional Medicinal Plants

Survey Near Lal Suhanra National Park Identifies Thirty Traditional Medicinal Plants

November 20, 2026

Cochlear Protein Degradation Machinery Regulates Sensorineural Hearing Loss Across Pathological Pathways

November 20, 2026

Intensive Mind-Body Retreat Linked to Reversible Stress and Immune Gene Expression Changes

November 20, 2026

POPULAR NEWS

  • CMOS Potts Chip Harnesses Multiphase Oscillations for Low-Power Memory and Graph Optimization

    CMOS Potts Chip Harnesses Multiphase Oscillations for Low-Power Memory and Graph Optimization

    29 shares
    Share 12 Tweet 7
  • Optimized Radiolabeling Improves iPSMA Homogeneity and Supports Single Vial Cold Kit Formulation

    29 shares
    Share 12 Tweet 7
  • Cross-Sectional Bahrain Survey Links Weather, Demands, and Gender to Activity Rates

    29 shares
    Share 12 Tweet 7
  • Biologists Propose Teleonome Framework to Assess Animal Welfare and Agency

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Continuous Rough Set Valuation Enables Dynamic Coalition Formation in Relational Games

Direct Acid Leaching of Morupule B Coal Fly Ash Limits Rare-Earth Recovery

SARS-CoV-2 Beta Variant Drives Acute Lung Immune Activation in Wild-Type Mice

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 89 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.